Over the past four years with the opportunity provided by the P30 CCMBM grant, our loosely organized set of musculoskeletal labs has developed into a well-respected Musculoskeletal Research Center with 75 members from 22 Departments, over 250 publications (158 in Reporter), a new facility with 12 musculoskeletal labs co-localized with the Administration and Research Cores, an active and productive Pilot and Feasibility Program, a popular Musculoskeletal Seminar Series and well-attended Annual Symposia. Our fields of interest have covered a wide variety of common musculoskeletal disorders from osteoporosis to osteoarthritis to tendon injuries to cancer. We now have $59 million in funding with $35 million from the NIH, and were recently awarded a T32 Training grant in Skeletal Metabolic Diseases. During the next five years, we plan to grow our Center to include a wider range of research interests stemming from our larger and more diverse research base, such as cancer metastasis to bone, scoliosis and intervertebral disc disease, tendon to bone healing, cartilage repair and stem cells in regenerative medicine. Our enrichment program will be expanded to include mentoring activities and training and education in specialized research techniques. The CCMBM enables the offering of many new services that will help drive the science of the research base, such as an expansion of the animal models to include zebrafish, isolation of specific populations of cells using histology and new non-invasive techniques to monitor tissue quality. Our Research Cores are: Core B: Musculoskeletal Structure and Strength, Core C: Histology and Morphometry, and Core D: Animal Models. With the help of the ICTS, we are very excited to include a new emphasis on translation of our animal research to the patient. The CCMBM will continue to provide leadership in promoting quality research, foster collaborations and interdisciplinary approaches, expand the ranks of the research base and help drive the science of musculoskeletal investigators by providing increasingly sophisticated and powerful technologies through our research cores.

Public Health Relevance

Musculoskeletal disorders such as osteoarthritis, osteoporosis and muscular dystrophy are a main cause of pain and suffering leading to diminished quality and lost time from work. Our research uses animal models to understand the biological factors underlying musculoskeletal disorders. We use histology, imaging and mechanical testing techniques to assess the structure and strength of bone, tendon and muscle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR057235-09
Application #
9269143
Study Section
Special Emphasis Panel (ZAR1-XZ (M1))
Program Officer
Tyree, Bernadette
Project Start
2009-05-11
Project End
2019-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
9
Fiscal Year
2017
Total Cost
$488,832
Indirect Cost
$168,286
Name
Washington University
Department
Orthopedics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Rohatgi, Nidhi; Zou, Wei; Collins, Patrick L et al. (2018) ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1. Blood Adv 2:2467-2477
Brophy, R H; Zhang, B; Cai, L et al. (2018) Transcriptome comparison of meniscus from patients with and without osteoarthritis. Osteoarthritis Cartilage 26:422-432
Sun, David; Brodt, Michael D; Zannit, Heather M et al. (2018) Evaluation of loading parameters for murine axial tibial loading: Stimulating cortical bone formation while reducing loading duration. J Orthop Res 36:682-691
Turecamo, S E; Walji, T A; Broekelmann, T J et al. (2018) Contribution of metabolic disease to bone fragility in MAGP1-deficient mice. Matrix Biol 67:1-14
Meyer, Gretchen A (2018) Evidence of induced muscle regeneration persists for years in the mouse. Muscle Nerve 58:858-862
Wang, Chun; Hockerman, Susan; Jacobsen, E Jon et al. (2018) Selective inhibition of the p38? MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med 215:1315-1325
Chinzei, N; Brophy, R H; Duan, X et al. (2018) Molecular influence of anterior cruciate ligament tear remnants on chondrocytes: a biologic connection between injury and osteoarthritis. Osteoarthritis Cartilage 26:588-599
Rai, Muhammad Farooq; Tycksen, Eric D; Sandell, Linda J et al. (2018) Advantages of RNA-seq compared to RNA microarrays for transcriptome profiling of anterior cruciate ligament tears. J Orthop Res 36:484-497
Chinzei, Nobuaki; Rai, Muhammad Farooq; Hashimoto, Shingo et al. (2018) Evidence for Genetic Contribution to Variation in Post-Traumatic Osteoarthritis in Mice. Arthritis Rheumatol :
Rai, Muhammad Farooq; Pham, Christine Tn (2018) Intra-articular drug delivery systems for joint diseases. Curr Opin Pharmacol 40:67-73

Showing the most recent 10 out of 335 publications